Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Post-ACS patients with history of IS/TIA previously to the acute coronary event and taking aspirin
- Sign the consent form

Exclusion Criteria

- Hemorrhagic stroke
- Another antiplatelet drug than aspirin
- Use of Anti inflammatory drug
- Severe chronic kidney dysfunction
- Liver disease
- Coagulopathy
- Platelet disfunction
- Thrombocytopenia or thrombocytosis
- Refuse to sign the consent form